Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Abivax S.A. buy melinda

Abivax S.A.
Start price
€11.04
27.01.19 / 50%
Target price
€16.00
29.07.19
Performance (%)
-13.50%
End price
€9.55
29.07.19
Summary
This prediction ended on 29.07.19 with a price of €9.55. The price of Abivax S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.50%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Abivax S.A. - - - -
iShares Core DAX® 0.734% -0.964% 17.910% 65.510%
iShares Nasdaq 100 -2.686% -2.409% 4.267% 95.368%
iShares Nikkei 225® -2.261% -4.038% 10.420% 42.232%
iShares S&P 500 -1.346% -1.510% 1.615% 59.132%

According to melinda what are the pros and cons of Abivax S.A. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by melinda for this prediction

In the thread Abivax S.A. diskutieren
Prediction Buy
Perf. (%) -13.50%
Target price 16.000
Change
Ends at 29.07.19

Secteur Recherche biotechnologique et médicale Agenda 30/01 | 12:30 Investor Meeting




    
        
    métier
Logo Abivax
Abivax est une société de biotechnologie spécialisée dans le ciblage du système immunitaire pour éliminer les maladies virales. Le groupe dispose de trois plateformes technologiques: une plateforme «antivirale», «stimulation immunitaire» et «anticorps polyclonaux». Phase II study afin de devenir un élément de guérison du VIH / SIDA. ABX464 est une nouvelle molécule administrée par voie orale qui inhibe la réplication virale via un mode d'action unique et qui présente un fort effet anti-inflammatoire. Abivax est également immuno-stimulant en phase clinique. (Chikungunya, Ebola, Dengue, etc.).

Nombre d'employés : 24 personnes.

melinda 
0
Report Share
27.01.19
Prediction Buy
Perf. (%) -13.50%
Target price 16.000
Change
Ends at 29.07.19

(Laufzeit überschritten)

melinda 
0
Report Share
29.07.19

Stopped prediction by melinda for Abivax S.A.

buy
Abivax S.A.

Start price
Target price
Perf. (%)
€9.10
04.08.22
-
04.08.23
81.32%
05.08.23

Could be very worthwhile Investment >20% year
melinda 
04.08.22 50%
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€9.85
07.11.19
€28.00
04.11.21
184.77%
05.11.21

Could be very worthwhile Investment >20% year
melinda 
07.11.19 50%
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€8.60
21.12.17
€15.00
21.06.18
-19.53%
21.06.18

Could be very worthwhile Investment >20% year
melinda 
18.08.19 50%
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€6.00
17.02.17
€10.00
03.04.17
17.33%
03.04.17

Could be very worthwhile Investment >20% year
melinda 
14.08.19 50%
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€10.80
26.04.16
€20.00
26.10.16
-29.35%
26.10.16

Could be very worthwhile Investment >20% year
melinda 
14.08.19 50%